These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9712186)

  • 1. Chronic dosing with 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, modulates NMDA inhibition of muscarinic-coupled PI hydrolysis in rat cortical slices.
    Boje KM; Lakhman SS
    Neurochem Res; 1998 Sep; 23(9):1167-74. PubMed ID: 9712186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effects of NMDA on phosphoinositide responses evoked by the metabotropic glutamate receptor agonist 1S,3R-ACPD in neonatal rat cerebral cortex.
    Challiss RA; Mistry R; Gray DW; Nahorski SR
    Br J Pharmacol; 1994 May; 112(1):231-9. PubMed ID: 7913380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
    Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
    Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons.
    Lin Y; Fossom LH; Skolnick P; Long JB
    Eur J Pharmacol; 1998 Sep; 356(2-3):255-60. PubMed ID: 9774257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of muscarinic cholinoceptor-stimulated inositol 1,4,5-trisphosphate accumulation by N-methyl-D-aspartate in neonatal rat cerebral cortex.
    Challis RA; Mistry R; Gray DW; Nahorski SR
    Neuropharmacology; 1994 Jan; 33(1):15-25. PubMed ID: 7910385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
    Fossom LH; Basile AS; Skolnick P
    Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium influx via ionotropic glutamate receptors causes long lasting inhibition of metabotropic glutamate receptor-coupled phosphoinositide hydrolysis.
    Facchinetti F; Hack NJ; Balázs R
    Neurochem Int; 1998 Sep; 33(3):263-70. PubMed ID: 9759922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
    Boje KM; Wong G; Skolnick P
    Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phencyclidine recognition site is associated with N-methyl-D-aspartate inhibition of carbachol-stimulated phosphoinositide hydrolysis in rat cortical slices.
    Gonzales RA; Moerschbaecher JM
    Mol Pharmacol; 1989 Jun; 35(6):787-94. PubMed ID: 2543912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NMDA on carbachol-stimulated phosphatidylinositol resynthesis in rat brain cortical slices.
    Lee HM; Huang CL
    Neurochem Res; 1997 May; 22(5):607-14. PubMed ID: 9131640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glycine antagonist 7-chlorokynurenic acid blocks the effects of N-methyl-D-aspartate on agonist-stimulated phosphoinositide hydrolysis in guinea-pig brain slices.
    Kendall DA; Robinson JP
    J Neurochem; 1990 Dec; 55(6):1915-9. PubMed ID: 1977886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex.
    Mistry R; Wilke R; Challiss RA
    Br J Pharmacol; 1995 Feb; 114(4):797-804. PubMed ID: 7773540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-aminocyclopropanecarboxylic acid on N-methyl-D-aspartate-stimulated [3H]-noradrenaline release in rat hippocampal synaptosomes.
    Clos MV; Garcia Sanz A; Trullas R; Badia A
    Br J Pharmacol; 1996 Jun; 118(4):901-4. PubMed ID: 8799560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute or prolonged exposure to 1-aminocyclopropanecarboxylic acid protects spinal neurons against NMDA toxicity.
    Lin Y; Long JB
    Eur J Pharmacol; 1996 Dec; 318(2-3):491-6. PubMed ID: 9016943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex.
    Skolnick P; Miller R; Young A; Boje K; Trullas R
    Psychopharmacology (Berl); 1992; 107(4):489-96. PubMed ID: 1534910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in agonist and antagonist activities for two indices of metabotropic glutamate receptor-stimulated phosphoinositide turnover.
    Mistry R; Challiss RA
    Br J Pharmacol; 1996 Apr; 117(8):1735-43. PubMed ID: 8732284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
    Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR
    Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
    Fink K; Schultheiss R; Göthert M
    Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.